Pfizer-Mylan Generic Giant Solves Two Problems With One Deal

Bookmark
(Bloomberg Opinion) -- The merger of Pfizer Inc.'s off-patent drug business with struggling specialty drugmaker Mylan Inc., announced early Monday morning, should come as a relief for investors on ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.